Treatment of visceral leishmaniasis.
Ozsoylu
Sinasi
S
D000666:Amphotericin B / Q000627:therapeutic use*; D000743:Anemia, Hemolytic / Q000150:complications*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D003298:Coombs Test; D006801:Humans; D007223:Infant; D007898:Leishmaniasis, Visceral / Q000150:complications / Q000188:drug therapy*; D008081:Liposomes
D000981:Antiprotozoal Agents; D008081:Liposomes; D000666:Amphotericin B